Fig. 1From: JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysisFlow diagram of study identification and assessment for eligibility. Two hundred twenty seven and 504 studied were identified from the databases Medline and MedRxIV, respectively. Two additional articles were added by manually searching retrieved reviews. Two articles were removed as duplicates. Six hundred ninety eight were removed after title and abstract screening not meeting inclusion criteria. Eighteen articles were removed after evaluation of the full article, with 15 included articles remainingBack to article page